Amgen’s Vectibix Helps in Second-Line Cancer Therapy

Amgen’s colon cancer drug Vectibix helped patients live longer without their disease progressing when used as a second-line treatment, researchers told Europe’s top cancer meeting on Tuesday.
Yahoo! Finance UK & Ireland